Novavax, Inc. - Strategy, SWOT and Corporate Finance Report
Summary
Novavax, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
- Novavax Inc. (Novavax or 'the company') is a biotechnology company that discovers and develops vaccines for the prevention of serious infectious diseases. The company's major offerings include various vaccine candidates against respiratory syncytial virus (RSV), seasonal influenza, and the Ebola virus. Novavax markets vaccine candidates under Novavax, ResVax, Resolve, Prepare, Matrix, and NanoFlu brand names. It uses innovative proprietary recombinant nanoparticle vaccine technologies to develop various vaccines related to emerging disease threats. The company also develops various adjuvant formulations through proprietary Matrix technology. It operates manufacturing facilities in Gaithersburg, Maryland and Uppsala, Sweden. The company is headquartered in Gaithersburg, Maryland, the US.
- Detailed information on Novavax, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novavax, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Novavax, Inc. including a breakdown and examination of key business segments
- Intelligence on Novavax, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novavax, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends Reaasons to Buy
- Gain understanding of Novavax, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novavax, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novavax, Inc.'s business structure, strategy and prospects.
- Company Snapshot
- Novavax, Inc.: Company Overview
- Novavax, Inc.: Overview and Key Facts
- Novavax, Inc.: Overview
- Novavax, Inc.: Key Facts
- Novavax, Inc.: Key Employees
- Novavax, Inc.: Key Employee Biographies
- Novavax, Inc.: Major Products and Services
- Novavax, Inc.: Company History
- Novavax, Inc.: Management Statement
- Novavax, Inc.: Locations and Subsidiaries
- Novavax, Inc.: Key Competitors
- Novavax, Inc.: Company Analysis
- Novavax, Inc.: Business Description
- Novavax, Inc.: SWOT Analysis
- Novavax, Inc.: SWOT Overview
- Novavax, Inc.: Strengths
- Novavax, Inc.: Weaknesses
- Novavax, Inc.: Opportunities
- Novavax, Inc.: Threats
- Novavax, Inc.: Corporate Financial Deals Activity
- Novavax, Inc.: Financial Deals Overview
- Novavax, Inc.: Targets and Partners
- Novavax, Inc.: Top Deals 2018 - 2022YTD*
- Novavax, Inc.: Advisors
- Novavax, Inc.: Top Legal Advisors
- Novavax, Inc.: Top Financial Advisors
- Novavax, Inc.: Mergers and Acquisitions
- Novavax, Inc.: Capital Raising
- Novavax, Inc.: Partnership
- Novavax, Inc.: Divestments
- Novavax, Inc.: Private Equity and Ownership
- Novavax, Inc.: Recent Developments
- Novavax, Inc.: News and Events Summary
- Novavax, Inc.: Corporate Governance
- Novavax, Inc.: Financial Performance
- Novavax, Inc.: Market Developments
- Novavax, Inc.: Regulatory and Legal Events
- Novavax, Inc.: Research & Development
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: Novavax, Inc.: Key Facts
- Table 2: Novavax, Inc.: Key Employees
- Table 3: Novavax, Inc.: Company History
- Table 4: Novavax, Inc.: Locations and Subsidiaries
- Table 5: Novavax, Inc.: Key Competitors
- Table 6: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 7: Novavax, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Table 8: Novavax, Inc.: M&A Average Deal Size - Value (US$m)
- Table 9: Novavax, Inc.: Targets and Partners
- Table 10: Novavax, Inc.: Top Deals 2018 - 2022YTD*
- Table 11: Novavax, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 12: Novavax, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 13: Novavax, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
- Table 14: Novavax, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
- Table 15: Novavax, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
- Table 16: Novavax, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Table 17: Novavax, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
- Table 18: Novavax, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
- Table 19: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022)
- Table 20: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)
- Table 21: Novavax, Inc.: News and Events Summary
- Table 22: Novavax, Inc.: Corporate Governance
- Table 23: Novavax, Inc.: Financial Performance
- Table 24: Novavax, Inc.: Market Developments
- Table 25: Novavax, Inc.: Regulatory and Legal Events
- Table 26: Novavax, Inc.: Research & Development
- List of Figures
- Figure 1: CarMax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: CarMax, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Figure 3: CarMax, Inc.: M&A Average Deal Size - Value (US$m)
- Figure 4: CarMax, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
- Figure 5: CarMax, Inc.: M&A Activity by Geography (2018 - YTD*2022)
- Figure 6: CarMax, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Figure 7: CarMax, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook